Fas Ligand-deficient Mice Display Enhanced Leukocyte Infiltration and Intima Hyperplasia in Flow-restricted Vessels
- 31 August 2000
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 32 (8) , 1395-1400
- https://doi.org/10.1006/jmcc.2000.1176
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand–Induced Cell DeathArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Negative Regulation of Inflammation by Fas Ligand Expression on the Vascular EndotheliumTrends in Cardiovascular Medicine, 1999
- Oxidized LDL activates fas-mediated endothelial cell apoptosis.Journal of Clinical Investigation, 1998
- Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: A lesson from the mouse modelJournal of Human Genetics, 1998
- Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and MacrophagesThe Journal of Experimental Medicine, 1997
- Fas ligand mediates activation-induced cell death in human T lymphocytes.The Journal of Experimental Medicine, 1995
- Fas ligation triggers apoptosis in macrophages but not endothelial cellsEuropean Journal of Immunology, 1994
- Mouse model of arterial injury.Circulation Research, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.The Journal of Experimental Medicine, 1978